Featured Spatial Biology & Sequencing Solutions
The Landscape of Spatially Resolved Transcriptomics in the UAE
The United Arab Emirates (UAE) has rapidly established itself as a pioneering hub for biotechnology and genomic sciences in the Middle East. Driven by visionary initiatives such as the Emirati Genome Program and significant investments in healthcare infrastructure across Abu Dhabi and Dubai, the region is transitioning from standard molecular diagnostics to cutting-edge spatial biology. Spatially Resolved Transcriptomics (SRT) stands at the forefront of this revolution, enabling researchers and clinicians to map gene expression profiles directly onto tissue sections, preserving the crucial spatial architecture of cellular microenvironments.
Unlike traditional bulk or single-cell RNA sequencing, which requires tissue dissociation and consequently loses the spatial coordinates of transcripts, Spatially Resolved Transcriptomics retains the histological context. In the UAE's rapidly expanding academic and industrial research landscape, this technology is unlocking new paradigms in oncology, metabolic disorder research, rare genetic disease mapping, and agricultural biotechnology adapted to arid climates.
By mapping the cellular landscape with high resolution, SRT allows UAE clinical researchers to dissect tumor microenvironments specific to regional cohorts, understand tissue-specific responses to therapeutics, and characterize cellular variations in complex metabolic diseases like diabetes and obesity, which present high prevalence rates in the Gulf Cooperation Council (GCC) region.
Local Application Scenarios in the UAE
1. Precision Oncology & Immunotherapy
Cancer clinics and research entities in Dubai Health City and Abu Dhabi’s Khalifa University are leveraging spatial transcriptomics to dissect the complex tumor microenvironment (TME). By understanding where immune cells, stromal cells, and malignant cells reside relative to one another, scientists can identify biomarkers that predict patient response to immunotherapies. This spatial localization is key to developing personalized therapeutic strategies for highly heterogeneous cancers prevalent in the region, such as breast and colorectal cancers.
2. Rare and Inherited Genetic Disorders
The Middle East faces unique challenges regarding consanguineous genetic variations and rare congenital diseases. Spatially Resolved Transcriptomics offers unprecedented details during developmental biology studies and tissue pathology analysis. It enables researchers to identify localized gene expression aberrations in affected tissues, paving the way for targeted gene therapies and diagnostic assays tailored to the genetic structure of the local population.
3. Desert Agriculture & Marine Biotechnology
The UAE’s National Food Security Strategy 2051 emphasizes the development of climate-resilient agricultural systems. Local universities are applying spatial transcriptomics to plant biology, analyzing how desert plants and staple crops like the Date Palm respond to extreme salinity and heat stress at the cellular boundary layer. Similarly, marine biologists in Abu Dhabi utilize SRT to study coral reef resilience in the Persian Gulf, discovering spatial gene networks that allow marine organisms to survive in some of the warmest waters on Earth.
Biomarker Technologies (BMKGene): Pioneers in Spatial Genomics
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Leading Multi-level High-throughput Sequencing Platforms
To support advanced research in spatial biology and multi-omics, BMKGene operates an extensive suite of cutting-edge technological platforms. Our state-of-the-art laboratory infrastructure guarantees high-precision data output for global and regional projects, including clinical and agricultural genomic studies in the UAE.
Sequencing Platforms
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
Over 20,000 Square Feet Facility
Advanced biomolecular laboratory instruments designed for high-throughput multi-omics execution.
Standardized laboratories dedicated to sample extraction, library construction, clean rooms, and sequencing operations.
Strict Standard Operating Procedures (SOPs) governing the entire pipeline from raw sample extraction to final sequencing data delivery.
BMKCloud Bioinformatic Platform
Self-developed BMKCloud platform offering reliable, easy-to-use online bioinformatic analysis.
High-performance computing structure: CPUs with 41,104 memory and 3 PB total storage capacity.
4,260 computing cores delivering a peak computing power exceeding 121,708.8 Gflop per second.
Fully Automated Platform for Next-generation sequencing — Brilliant Lab 1000
Biomarker Technologies (BMKGene) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to high-throughput NGS library construction services.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services worldwide, including the expanding scientific community in the UAE.
Our State-of-the-Art Facilities
Enterprise Qualifications & Global Certifications
Our commitment to quality is backed by international standards, academic partnerships, and intellectual property. We maintain rigorous standards to ensure the highest reliability for all genomic and spatial transcriptomic projects.
